NCT06038279 - Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions

Allergic Rhinitis Due to Weed PollenAllergic Rhinitis

Interventions

DRUG

INI-2004

INI-2004 (a toll-like receptor \[TLR\]4 agonist) liposomal formulation. INI-2004 is an intranasal (IN) TLR4 agonist that is targeted to prevent AR symptoms in subjects with seasonal AR.

DRUG

Placebo

The Placebo for INI-2004 is a clear, colorless solution free of particles supplied in 10 mL glass vials with a 10 mL fill.

Trial Locations (1)

3004

RECRUITING

Nucleus Network Pty Ltd, Melbourne